Penatalaksanaan COVID-19 Pada Penderita Penyakit Ginjal

Bilah Samping Artikel

Diterbitkan Jul 12, 2022
https://doi.org/10.30651/ps.v1i1.13709
Download
PDF
Statistic
Vol 1 No 1 (2022): PROSIDING WEBINAR FAKULTAS KEDOKTERAN UNIVERSITAS MUHAMMADIYAH SURABAYA

Isi Artikel Utama

Siti Cholishotul H
Profesi Kedokteran Universitas Muhammadiyah Surabaya
Abdur Rohman
Dosen Profesi KSM Ilmu Penyakit Dalam RSUD dr. SOEGIRI Lamongan

Abstrak

Abstract

Covid-19 is acute respiratory syndrome due to Coronavirus SARCoV-2 infection. Virus attaches to angiotensin converting enzyme 2 (ACE2) receptor, besides the lungs, this receptor also expressed by cells in kidney causes renal insufficiency. Covid-19 patients with chronic kidney disease (CKD) management is the same as other Covid-19 patients, antivirals, renal function replacement therapy, and supportive therapies. ERA-EDTA Europe, reported 5596 cases of Covid-19 and 1331 deaths among hemodialysis patients in 2020. Concerns about the vulnerability of CKD patients group are increasing amid the pandemic. Standard operating procedures have proven effective in preventing the spread of Covid-19 among CKD patients undergoing hemodialysis.

Keywords : COVID-19, chronic kidney disease (CKD), therapy, preventive

Rincian Artikel

Referensi

  1. Daftar Pustaka
  2. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. American Journal of Hypertension. 2020; 33(5): p. 373-374.
  3. Tarragóna B, Valdenebro M, Serrano ML, Maroto A, Llópez-Carratalá MR, Ramos A, et al. Acute kidney failure in patients admitted due to COVID-19. Nefrologia. 2021;: p. 34-40.
  4. Center Disease Control. Chronic kidney disease in United State. [Online].; 2019 [cited 2021 11 09. Available from: https://www.cdc.gov/kidneydisease/publication-resources/2019-national-facts.html.
  5. Askari H, Sanadgol N, Azarnezhad A, Amir T, Rafiei H, Safarpour AR, et al. Kidney diseases and COVID-19 infection: cause and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;: p. 1-15.
  6. Rudiansyah M, Nur'amin HW, Lubis L, Bandiara R, Roesli RMA, Rachmadi D. COVID-19 dan Penyakit Ginjal di Indonesia. Sys Rev Pharm. 2020; 11(7): p. 435-441.
  7. Pan American Health Organization. MANAGING PEOPLE WITH KIDNEY DISEASE DURING COVID-19. [Online].; 2020 [cited 2021 11 07. Available from: www.paho.org/coronavirus.
  8. Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. COVID-19 and the Kidney: From Epidemiology to Clinical Practice. Clinical Medicine. 2020;(2506): p. 1-29.
  9. Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, et al. COVID-19 and chronic kidney disease: a comprehensive review. Braz. J. Nephrol. (J. Bras. Nefrol.). 2021;: p. 383-399.
  10. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395: p. 739-733.
  11. Novianty D. GAGAL GINJAL AKUT SEBAGAI KOMPLIKASI COVID-19: LITERATURE review. Indonesian Journal of Nursing and Health Sciences. 2020;: p. 63-72.